(US) 81 bipartisan legislators press FDA to investigate compounded fake GLP-1s in letter
Friday, July 25, 2025 12:01:05 PMEST
- FOLLOW UP: 17:08ET: FDA says it will provide a thorough to legislators on their concerns about GLP-1s
**Reminder: 06/23 HIMS Novo Nordisk confirms to terminate collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing; In late April, the FDA resolved the Wegovy shortage based on its conclusion that Novo Nordisk is fully meeting current and projected nationwide demand for this medicine. In support of transitioning patients from knock-off compounded versions to authentic, FDA-approved Wegovy through NovoCare Pharmacy, Novo Nordisk began collaborating with telehealth companies. Over one month into the collaboration, Hims & Hers Health, Inc. has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of "personalization" and are disseminating deceptive marketing that put patient safety at risk.
~
**Reminder: 06/23 HIMS Novo Nordisk confirms to terminate collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing; In late April, the FDA resolved the Wegovy shortage based on its conclusion that Novo Nordisk is fully meeting current and projected nationwide demand for this medicine. In support of transitioning patients from knock-off compounded versions to authentic, FDA-approved Wegovy through NovoCare Pharmacy, Novo Nordisk began collaborating with telehealth companies. Over one month into the collaboration, Hims & Hers Health, Inc. has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of "personalization" and are disseminating deceptive marketing that put patient safety at risk.